Pacific Biosciences of California, Inc. (PACB) Reports Q4 Loss of $0.42
Pacific Biosciences of California, Inc. (NASDAQ: PACB) reported Q4 EPS of ($0.42), $0.08 better than the analyst estimate of ($0.50). Revenue for the quarter came in at $12.5 million versus the consensus estimate of $10.34 million.
For earnings history and earnings-related data on Pacific Biosciences of California, Inc. (PACB) click here.
For earnings history and earnings-related data on Pacific Biosciences of California, Inc. (PACB) click here.